Multivariate analysis of survival for IDO1 protein in the Yale hormone-receptor positive breast cancer collection

20-year OS
HR(95% C.I.)P value
Age > 50 years2.26(1.59-3.39)< 0.0001
Tumor size >2 cm2.11(1.59-2.81)< 0.0001
Lymph node positive status1.43(1.00-2.01)0.05
TNM Stage III1.02(0.67-1.56)0.91
IDO1-high status1.57(1.19-2.09)0.002